Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis

NCT ID: NCT02914522

Last Updated: 2021-04-21

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

1351 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-11-14

Study Completion Date

2020-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objectives of this study are to evaluate the efficacy of filgotinib in the induction and maintenance treatment of moderately to severely active ulcerative colitis (UC) in participants who are biologic-naive and biologic-experienced.

Participants who complete the study, or met protocol specified efficacy discontinuation criteria will have the option to enter a separate, long-term extension (LTE) study (Gilead Study GS-US-418-3899: NCT02914535).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ulcerative Colitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Induction Study (Cohort A): Filgotinib 200 mg

Participants in Cohort A (biologic-naive) received filgotinib 200 milligrams (mg) and placebo-to-match (PTM) filgotinib 100 mg orally once daily for 10 weeks.

Group Type EXPERIMENTAL

Filgotinib

Intervention Type DRUG

Tablet(s) administered orally once daily

PTM filgotinib

Intervention Type DRUG

Tablet(s) administered orally once daily

Induction Study (Cohort A): Filgotinib 100 mg

Participants in Cohort A (biologic-naive) received filgotinib 100 mg and PTM filgotinib 200 mg orally once daily for 10 weeks.

Group Type EXPERIMENTAL

Filgotinib

Intervention Type DRUG

Tablet(s) administered orally once daily

PTM filgotinib

Intervention Type DRUG

Tablet(s) administered orally once daily

Induction Study (Cohort A): Placebo

Participants in Cohort A (biologic-naive) received PTM filgotinib 200 mg and PTM filgotinib 100 mg orally once daily for 10 weeks.

Group Type PLACEBO_COMPARATOR

PTM filgotinib

Intervention Type DRUG

Tablet(s) administered orally once daily

Induction Study (Cohort B): Filgotinib 200 mg

Participants in Cohort B (biologic-experienced) received filgotinib 200 mg and PTM filgotinib 100 mg orally once daily for 10 weeks.

Group Type EXPERIMENTAL

Filgotinib

Intervention Type DRUG

Tablet(s) administered orally once daily

PTM filgotinib

Intervention Type DRUG

Tablet(s) administered orally once daily

Induction Study (Cohort B): Filgotinib 100 mg

Participants in Cohort B (biologic-experienced) received filgotinib 100 mg and PTM filgotinib 200 mg orally once daily for 10 weeks.

Group Type EXPERIMENTAL

Filgotinib

Intervention Type DRUG

Tablet(s) administered orally once daily

PTM filgotinib

Intervention Type DRUG

Tablet(s) administered orally once daily

Induction Study (Cohort B): Placebo

Participants in Cohort B (biologic-experienced) received PTM filgotinib 200 mg and PTM filgotinib 100 mg orally once daily for 10 weeks.

Group Type PLACEBO_COMPARATOR

PTM filgotinib

Intervention Type DRUG

Tablet(s) administered orally once daily

Maintenance Study: Filgotinib 200 mg From Induction Filgotinib 200 mg

Participants in the Filgotinib 200 mg arm who completed the Induction Study and achieved either Endoscopy/Bleeding/Stool Frequency (EBS) remission or Mayo Clinic Score (MCS) response at Week 10 were re-randomized at Week 11 into the Maintenance Study to receive filgotinib 200 mg and PTM filgotinib 100 mg for an additional 47 weeks (up to Week 58).

Group Type EXPERIMENTAL

Filgotinib

Intervention Type DRUG

Tablet(s) administered orally once daily

PTM filgotinib

Intervention Type DRUG

Tablet(s) administered orally once daily

Maintenance Study: Placebo From Induction Filgotinib 200 mg

Participants in the Filgotinib 200 mg arm who completed the Induction Study and achieved either EBS remission or MCS response at Week 10 were re-randomized at Week 11 into the Maintenance Study to receive PTM filgotinib orally once daily for an additional 47 weeks (up to Week 58).

Group Type PLACEBO_COMPARATOR

PTM filgotinib

Intervention Type DRUG

Tablet(s) administered orally once daily

Maintenance Study: Filgotinib 100 mg From Induction Filgotinib 100 mg

Participants in the Filgotinib 100 mg arm who completed the Induction Study and achieved either EBS remission or MCS response at Week 10 were re-randomized at Week 11 into the Maintenance Study to receive filgotinib 100 mg and PTM filgotinib 200 mg for an additional 47 weeks (up to Week 58).

Group Type EXPERIMENTAL

Filgotinib

Intervention Type DRUG

Tablet(s) administered orally once daily

PTM filgotinib

Intervention Type DRUG

Tablet(s) administered orally once daily

Maintenance Study: Placebo From Induction Filgotinib 100 mg

Participants in the Filgotinib 100 mg arm who completed the Induction Study and achieved either EBS remission or MCS response at Week 10 were rerandomized at Week 11 into the Maintenance Study to receive PTM filgotinib orally once daily for an additional 47 weeks (up to Week 58).

Group Type PLACEBO_COMPARATOR

PTM filgotinib

Intervention Type DRUG

Tablet(s) administered orally once daily

Maintenance Study: Placebo From Induction Placebo

Participants in the Placebo arm who completed the Induction Study and achieved either EBS remission or MCS response at Week 10 were re-randomized at Week 11 into the Maintenance Study to receive PTM filgotinib for an additional 47 weeks (up to Week 58).

Group Type PLACEBO_COMPARATOR

PTM filgotinib

Intervention Type DRUG

Tablet(s) administered orally once daily

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Filgotinib

Tablet(s) administered orally once daily

Intervention Type DRUG

PTM filgotinib

Tablet(s) administered orally once daily

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

GS-6034 GLPG0634

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males or non-pregnant, non-lactating females, ages 18 to 75 years, inclusive based on the date of the screening visit
* Documented diagnosis of UC of at least 6 months AND with a minimum disease extent of 15 cm from the anal verge. Documentation should include endoscopic and histopathologic evidence of UC.
* A surveillance colonoscopy is required at screening in individuals with a history of UC for 8 or more years, if one was not performed in the prior 24 months
* Moderately to severely active UC
* Previously demonstrated an inadequate clinical response, loss of response to, or intolerance to at least 1 of the following agents (depending on current country treatment recommendations/guidelines): corticosteroids, immunomodulators, tumor necrosis factor alpha (TNFa) antagonists, or vedolizumab

Exclusion Criteria

* Presence of Crohn's disease, indeterminate colitis, ischemic colitis, fulminant colitis, ulcerative proctitis, or toxic mega-colon
* Active tuberculosis (TB) or history of latent TB that has not been treated
* Use of any concomitant prohibited medications as described in the protocol
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Galapagos NV

INDUSTRY

Sponsor Role collaborator

Gilead Sciences

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gilead Study Director

Role: STUDY_DIRECTOR

Gilead Sciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Digestive Health Specialists of the Southeast

Dothan, Alabama, United States

Site Status

Mayo Clinic Arizona

Scottsdale, Arizona, United States

Site Status

VA Long Beach Healthcare System

Long Beach, California, United States

Site Status

Cedars Sinai Medical Center

Los Angeles, California, United States

Site Status

South Denver Gastroenterology, PC

Lone Tree, Colorado, United States

Site Status

Connecticut GI PC-Research Division

Farmington, Connecticut, United States

Site Status

UF Health at Shands Hospital

Gainesville, Florida, United States

Site Status

Florida Research Institute

Lakewood Rch, Florida, United States

Site Status

University of Miami Crohn's and Colitis Center

Miami, Florida, United States

Site Status

Cordova Research Institute

Miami, Florida, United States

Site Status

Gastroenterology Group of Naples

Naples, Florida, United States

Site Status

Advanced Medical Research Center

Port Orange, Florida, United States

Site Status

Tampa General Hospital

Tampa, Florida, United States

Site Status

Shafran Gastroenterology Center

Winter Park, Florida, United States

Site Status

Florida Medical Clinic, P.A.

Zephyrhills, Florida, United States

Site Status

Gastroenterology Associates of Central Georgia, LLC

Macon, Georgia, United States

Site Status

Gastrointestinal Specialists of Georgia

Marietta, Georgia, United States

Site Status

Atlanta Gastroenterology Specialist, PC

Suwanee, Georgia, United States

Site Status

University of Iowa Hospitals and Clinics

Iowa City, Iowa, United States

Site Status

University of Louisville, Clinical Trials Unit

Louisville, Kentucky, United States

Site Status

Delta Research Partners, LLC

Monroe, Louisiana, United States

Site Status

Louisiana Research Center, LLC

Shreveport, Louisiana, United States

Site Status

Investigative Clinical Research

Annapolis, Maryland, United States

Site Status

MGG Group Co., Inc., Chevy Chase Clinical Research

Chevy Chase, Maryland, United States

Site Status

Gastro Center of Maryland

Columbia, Maryland, United States

Site Status

Meritus Center for Clinical Research

Hagerstown, Maryland, United States

Site Status

Massachusetts General Hospital - Crohn's and Colitis Center

Boston, Massachusetts, United States

Site Status

Clinical Research Institute of Michigan, LLC

Chesterfield, Michigan, United States

Site Status

Center for Digestive Health

Troy, Michigan, United States

Site Status

Mayo Clinic

Rochester, Minnesota, United States

Site Status

Kansas City Research Institute

Kansas City, Missouri, United States

Site Status

Washington University School of Medicine

St Louis, Missouri, United States

Site Status

NY Scientific

Brooklyn, New York, United States

Site Status

NYU Langone Long Island Clinical Research Associates

Great Neck, New York, United States

Site Status

Carolina's GI Research, LLC

Raleigh, North Carolina, United States

Site Status

Fargo Gastroenterology and Hepatology Clinic

Fargo, North Dakota, United States

Site Status

Consultants for Clinical Research

Cincinnati, Ohio, United States

Site Status

UC Health Physicians Clifton

Cincinnati, Ohio, United States

Site Status

Great Lakes Gastroenterology Research, LLC

Mentor, Ohio, United States

Site Status

Gastroenterology Associates of Orangeburg

Orangeburg, South Carolina, United States

Site Status

Rapid City Medical Center

Rapid City, South Dakota, United States

Site Status

WR-ClinSearch, LLC

Chattanooga, Tennessee, United States

Site Status

Gastro One

Germantown, Tennessee, United States

Site Status

Quality Medical Research

Nashville, Tennessee, United States

Site Status

Vanderbilt University Medical Center - IBD Clinic

Nashville, Tennessee, United States

Site Status

San Antonio Military Medical Center

Fort Sam Houston, Texas, United States

Site Status

DHAT Research Institute

Garland, Texas, United States

Site Status

Baylor College of Medicine- Baylor Medical Center

Houston, Texas, United States

Site Status

The University of Texas Health Science Center at Houston

Houston, Texas, United States

Site Status

Clinical Associates in Research Therapeutics of America, LLC

San Antonio, Texas, United States

Site Status

Gastroenterology Research of San Antonio

San Antonio, Texas, United States

Site Status

Texas Digestive Disease Consultants

San Marcos, Texas, United States

Site Status

Texas Digestive Disease Consultants

Southlake, Texas, United States

Site Status

Spring Gastroenterology

The Woodlands, Texas, United States

Site Status

HP Clinical Research

Bountiful, Utah, United States

Site Status

University of Virginia Health System

Charlottesville, Virginia, United States

Site Status

Gastroenterology Associates Of Tidewater

Chesapeake, Virginia, United States

Site Status

Emeritas Research Group LLC

Lansdowne Town Center, Virginia, United States

Site Status

McGuire DVAMC

Richmond, Virginia, United States

Site Status

University of Wisconsin Hospital & Clinics

Madison, Wisconsin, United States

Site Status

Allegiance Research Specialists, LLC

Wauwatosa, Wisconsin, United States

Site Status

Instituto de Investigaciones Clinicas Mar del Plata

Mar del Plata, , Argentina

Site Status

Instituto Médico Cer

Quilmes, , Argentina

Site Status

St. Vincent's Hospital Sydney

Darlinghurst, New South Wales, Australia

Site Status

Nepean Hospital

Kingswood, New South Wales, Australia

Site Status

Coastal Digestive Health

Mountain Creek, Queensland, Australia

Site Status

Mater Misericordiae Ltd

South Brisbane, Queensland, Australia

Site Status

Princess Alexandra Hospital

Woolloongabba, Queensland, Australia

Site Status

The Queen Elizabeth Hospital

Woodville South, South Australia, Australia

Site Status

Monash Medical Centre

Clayton, Victoria, Australia

Site Status

Footscray Hospital

Footscray, Victoria, Australia

Site Status

Austin Health

Heidelberg, Victoria, Australia

Site Status

Cabrini Hospital

Malvern, Victoria, Australia

Site Status

Alfred Hospital

Melbourne, Victoria, Australia

Site Status

Universitatsklinik Innsbruck

Innsbruck, , Austria

Site Status

AKH-Medizinische Universitat Wien

Vienna, , Austria

Site Status

GZA Ziekenhuizen campus Sint-Vincentius

Antwerp, , Belgium

Site Status

CUB Hopital Erasme

Brussels, , Belgium

Site Status

Universitair Ziekenhuis Leuven

Leuven, , Belgium

Site Status

Centre Hospitalier Chretien (CHC) - Clinique Saint-Joseph

Liège, , Belgium

Site Status

MHAT Sveti Pantaleymon - Pleven OOD

Pleven, , Bulgaria

Site Status

"MDHAT Dr. St.Cherkezov" AD

Veliko Tarnovo, , Bulgaria

Site Status

MHAT "Sveta Petka" AD

Vidin, , Bulgaria

Site Status

University of Calgary, Heritage Medical Research Clinic

Calgary, Alberta, Canada

Site Status

The Gordon and Leslie Diamond Health Care Centre

Vancouver, British Columbia, Canada

Site Status

Hamilton Health Sciences Corporation, McMaster University Medical Centre

Hamilton, Ontario, Canada

Site Status

Royal University Hospital

Saskatoon, Saskatchewan, Canada

Site Status

Toronto Digestive Disease Associates Inc.

Vaughan, , Canada

Site Status

Clinical Hospital Dubrava

Zagreb, , Croatia

Site Status

University Hospital Center Zagreb

Zagreb, , Croatia

Site Status

Hepato-Gastroenterologie HK, s.r.o.

Hradec Králové, , Czechia

Site Status

Oblastni nemocnice Mlada Boleslav, a.s., nemocnice Stredoceskeho kraje, Gastroenterologicke oddeleni

Mladá Boleslav, , Czechia

Site Status

G.E.P. Clinic, s r.o.

Prague, , Czechia

Site Status

ISCARE a.s. (Klinicke centrum ISCARE), Klinicke a vyzkumne centrum pro strevni zanety

Prague, , Czechia

Site Status

CHU Amiens Picardie

Amiens, , France

Site Status

CHU de Caen

Caen, , France

Site Status

CHU de Clermont-Ferrand - Hopital d'Estaing

Clermont-Ferrand, , France

Site Status

APHP - Hopital Beaujon - Clichy - Universite Paris VII

Clichy, , France

Site Status

CHU de Dijon Bourgogne - Hopital Francois Mitterand

Dijon, , France

Site Status

CHU Grenoble Alpes

La Tronche, , France

Site Status

Hopital Universitaire de Bicetre

Le Kremlin-Bicêtre, , France

Site Status

Centre Hospitalier Regional Universitaire de Lille

Lille, , France

Site Status

Hopital Nord

Marseille, , France

Site Status

CHU de Montpellier-Hopital Saint Eloi

Montpellier, , France

Site Status

CHU Hotel-Dieu

Nantes, , France

Site Status

Hopital de l'Archet 2

Nice, , France

Site Status

Institut Mutualiste Montsouris

Paris, , France

Site Status

CHU de Bordeaux - Hopital Haut Leveque

Pessac, , France

Site Status

Centre Hospitalier Universitaire de Lyon Sud

Pierre-Bénite, , France

Site Status

Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou

Rennes, , France

Site Status

CHU de Saint-Etienne - Hopital Nord

Saint-Priest-en-Jarez, , France

Site Status

CHU de Toulouse - Hopital Rangueil

Toulouse, , France

Site Status

CHU de Nancy - Hopital Brabois Adultes

Vandœuvre-lès-Nancy, , France

Site Status

Unimed Ajara LLC - Batumi Referral Hospital

Batumi, , Georgia

Site Status

Medi Club Georgia LLC

Tbilisi, , Georgia

Site Status

Ltd. Unimed Kakheti - Telavi Referral Hospital

Telavi, , Georgia

Site Status

Charite Universitatsmedizin Berlin

Berlin, , Germany

Site Status

Charite - Universitatsmedizin Berlin

Berlin, , Germany

Site Status

DRK Kliniken Berlin - Westend - Klinik fuer Innere Medizin

Berlin, , Germany

Site Status

Stadtisches Klinikum Braunschweig gGmbH

Braunschweig, , Germany

Site Status

Universitaetsklinik Koln

Cologne, , Germany

Site Status

Agaplesion Markus Krankenhaus

Frankfurt am Main, , Germany

Site Status

Universitatsklinikum Freiburg

Freiburg im Breisgau, , Germany

Site Status

Asklepios Westklinikum Hamburg

Hamburg, , Germany

Site Status

Medizinische Hochschule Hannover

Hannover, , Germany

Site Status

Gastroenterologische Gemeinschaftspraxis Herne

Herne, , Germany

Site Status

Universitatsklinikum Jena

Jena, , Germany

Site Status

Universitatsklinikum Schleswig-Holstein

Kiel, , Germany

Site Status

EUGASTRO GmbH

Leipzig, , Germany

Site Status

Klinikum Luneburg

Lüneburg, , Germany

Site Status

Gastroenterologische Gemeinschaftspraxis Minden

Minden, , Germany

Site Status

Klinikum der Universitat Munchen - Grosshadern

München, , Germany

Site Status

Universitaetsklinikum Tuebingen

Tübingen, , Germany

Site Status

Universitatsklinikum Ulm, Zentrum Fur Innere Medizin

Ulm, , Germany

Site Status

General Hospital of Athens "Hippokratio", 2nd Internal Medicine Clinic of Athens University, Hepato-gastroenterology Unit

Athens, , Greece

Site Status

General Hospital of Nikaias "Agios Pentelleimon", Gastroenterology Department

Athens, , Greece

Site Status

Princess Margaret Hospital

Hong Kong, , Hong Kong

Site Status

Queen Mary Hospital

Hong Kong, , Hong Kong

Site Status

Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital

Shatin, , Hong Kong

Site Status

Bekes Megyei Kosponti Korhaz, Dr. Rethy Pal Tagkorhaz, IV. Belgyogyaszat - 2. Gasztroenterologia

Békéscsaba, , Hungary

Site Status

Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet, Kozponti Felnott Szakrendelo

Budapest, , Hungary

Site Status

Szent Janos Korhaz es Eszak-budai Egitett Korhazak, I. Belgyogyaszati - Gasztroenterologiai Osztaly

Budapest, , Hungary

Site Status

Debreceni Egyetem Klinikai Kozpont, II. sz. Belgyogyaszati Klinika, Gasztroenterologia

Debrecen, , Hungary

Site Status

Bugat Pal Korhaz, Belgyogyaszat

Gyöngyös, , Hungary

Site Status

Karolina Korhaz es Rendelointezet, Altalanos Belgyogyaszat-Gasztroenterologia

Mosonmagyaróvár, , Hungary

Site Status

Kaizen Hospital

Ahmedabad, , India

Site Status

M S Ramaiah Medical College and Hospital

Bangalore, , India

Site Status

Apollo Speciality Hospital

Chennai, , India

Site Status

VGM Hospital Institute of Gastroenterology

Coimbatore, , India

Site Status

Gleneagles Global Hospitals

Hyderabad, , India

Site Status

Citizens Specialty Hospital

Hyderabad, , India

Site Status

Centre for Liver Research & Diagnostics

Hyderabad, , India

Site Status

S.R.KallaMemorial Gastro.&General Hospital,

Jaipur, , India

Site Status

S.M.S Medical College & Hospitals

Jaipur, , India

Site Status

School of Digestive & Liver Diseases

Kolkata, , India

Site Status

Dayanand Medical College & Hospital

Ludhiana, , India

Site Status

Kasturba Medical College (KMC) Hospital

Mangaluru, , India

Site Status

Lokmanya Tilak Municipal General Hospital

Mumbai, , India

Site Status

Midas Multispeciality Hospital Pvt. Ltd

Nagpur, , India

Site Status

Suretech Hospital & Research Centre Ltd

Nagpur, , India

Site Status

All India Institute of Medical Sciences

New Delhi, , India

Site Status

Grant Medical Foundation Ruby Hall Clinic

Pune, , India

Site Status

Shree Giriraj Multispeciality Hospital

Rajkot, , India

Site Status

Gandhi Hospital

Secunderabad, , India

Site Status

Institute of Gastroenterology & Liver Disease, Sunshine Hospitals

Secunderabad, , India

Site Status

Surat Institute of Digestive Sciences

Surat, , India

Site Status

Kasturba Hospital Medical College

Udupi, , India

Site Status

Sterling Hospital

Vadodara, , India

Site Status

Samvedana Hospital

Varanasi, , India

Site Status

Beaumont Hospital

Dublin, , Ireland

Site Status

Soroka Medical Center

Beersheba, , Israel

Site Status

Bnai Zion Medical Center

Haifa, , Israel

Site Status

Rambam Health Care Campus

Haifa, , Israel

Site Status

Shaare Zedek Medical Center

Jerusalem, , Israel

Site Status

Hadassah Medical Center

Jerusalem, , Israel

Site Status

Rabin Medical Center

Petah Tikva, , Israel

Site Status

UOC Gastroenterologia II

Castellana Grotte, , Italy

Site Status

U.O. Fisiopatologia Digestiva

Catanzaro, , Italy

Site Status

Ospedale Clinicizzato SS. Annunziata - Dipartimento di Medicina

Chieti, , Italy

Site Status

Endocsopia Digestiva Centralizzata - ASST Fatebenefratelli Sacco, Ospedale Fatebenefratelli e Oftalmico

Milan, , Italy

Site Status

UOC Gastroenterologia

Padua, , Italy

Site Status

Azienda Ospedaliero-Universitaria Pisana - Presidio Ospedaliero Cisanello

Pisa, , Italy

Site Status

UOC Gastroenterologia ed Endoscopia Digestiva

Roma, , Italy

Site Status

Istituto Clinico Humanitas

Rozzano, , Italy

Site Status

Medical Hospital, Tokyo Medical and Dental University

Bunkyō City, , Japan

Site Status

Fukuoka University Chikushi Hospital

Chikushino-shi, , Japan

Site Status

Hokkaido P.W.F.A.C Sapporo-Kosei General Hospital

Chūōku, , Japan

Site Status

Japanese Red Cross Fukuoka Hospital

Fukuoka, , Japan

Site Status

Tokai University Hachioji Hospital

Hachioji-shi, , Japan

Site Status

Hiroshima University Hospital

Hiroshima, , Japan

Site Status

Fukuoka University Hospital

Jonan-ku, , Japan

Site Status

Ofuna Chuo Hospital

Kamakura, , Japan

Site Status

Kitakyushu City Hospital Organization Kitakyushu Municipal Medical Center

Kitakyushu-shi, , Japan

Site Status

Yamanashi Prefectural Central Hospital

Kofu, , Japan

Site Status

Kurume University Hospital

Kurume-shi, , Japan

Site Status

Hidaka Coloproctology Clinic

Kurume-shi, , Japan

Site Status

University Hospital, Kyoto Prefectural University of Medicine

Kyoto, , Japan

Site Status

The Jikei University Hospital

Minatoku, , Japan

Site Status

Kitasato University Kitasato Institute Hospital

Minatoku, , Japan

Site Status

Kyorin University Hospital

Mitaka-shi, , Japan

Site Status

Iwate Medical University Hospital

Morioka, , Japan

Site Status

Aichi Medical University Hospital

Nagakute-shi, , Japan

Site Status

Nagasaki University Hospital

Nagasaki, , Japan

Site Status

Saiseikai Niigata Daini Hospital

Nishiku, , Japan

Site Status

Hyogo College of Medicine College Hospital

Nishinomiya, , Japan

Site Status

Okayama University Hospital

Okayama, , Japan

Site Status

Wakakusa-Daiichi Hospital

Osaka, , Japan

Site Status

Ishida IBD Clinic

Ōita, , Japan

Site Status

Kinshukai Infusion Clinic

Ōsaka, , Japan

Site Status

Osaka City University Hospital

Ōsaka, , Japan

Site Status

Shiga University of Medical Science Hospital

Ōtsu, , Japan

Site Status

Saga-Ken Medical Centre Koseikan

Saga, , Japan

Site Status

Saga University Hospital

Saga, , Japan

Site Status

Kitasato University Hospital, THE KITASATO INSTITUTE

Sagamihara, , Japan

Site Status

Tokito Clinic

Saitama, , Japan

Site Status

Toho University Sakura Medical Center

Sakura, , Japan

Site Status

Sapporo Tokushukai Hospital

Sapporo, , Japan

Site Status

Sapporo Higashi Tokushukai Hospital

Sapporo, , Japan

Site Status

National Hospital Organization Sendai Medical Center

Sendai, , Japan

Site Status

Tokyo Yamate Medical Center

Shinjuku-ku, , Japan

Site Status

Osaka University Hospital

Suita, , Japan

Site Status

Kagawa Prefectural Central Hospital

Takamatsu, , Japan

Site Status

National Hospital Organization Takasaki General Medical Center

Takasaki-shi, , Japan

Site Status

Osaka Medical College Hospital

Takatsuki, , Japan

Site Status

Ieda Hospital

Toyota-shi, , Japan

Site Status

Wakayama Medical University Hospital

Wakayama, , Japan

Site Status

Colo-proctology Center Matsushima Clinic

Yokohama, , Japan

Site Status

Yokohama Health Medicine Association Kannai Suzuki Clinic

Yokohama, , Japan

Site Status

University Kebangsaan Malaysia Medical Centre

Cheras, , Malaysia

Site Status

Hospital Pulau Pinang

George Town, , Malaysia

Site Status

Hospital Queen Elizabeth

Kota Kinabalu, , Malaysia

Site Status

PCR-Phylasis Clinicas Research S. de R.L. de C.V.

Cuautitlán Izcalli, , Mexico

Site Status

Academic Medical Center (AMC)

Amsterdam, , Netherlands

Site Status

Gelre Hospital

Apeldoorn, , Netherlands

Site Status

University Medical Center Utrecht

Utrecht, , Netherlands

Site Status

Christchurch Hospital

Christchurch, , New Zealand

Site Status

Auckland City Hospital

Grafton, , New Zealand

Site Status

Waikato Hospital

Hamilton, , New Zealand

Site Status

Wellington Hospital

Newtown, , New Zealand

Site Status

Bay of Plenty District Health Board - Tauranga Hospital

Tauranga, , New Zealand

Site Status

Vestre Viken Hospital Trust, Baerum Hospital

Drammen, , Norway

Site Status

Akerskus University Hospital

Lørenskog, , Norway

Site Status

Uniwersytecki Szpital Kliniczny w Bialymstoku, Klinika Gastroenterologii i Chorob Wewnetrznych

Bialystok, , Poland

Site Status

VITAMED Galaj i Cichomski spolka jawna

Bydgoszcz, , Poland

Site Status

Gabinet Lekarski Janusz Rudzinski

Bydgoszcz, , Poland

Site Status

NZOZ INTER-MED, Centrum Endoskopowe

Częstochowa, , Poland

Site Status

Niepubliczny Zaklad Opieki Zdrowotnej ALL-MEDICUS

Katowice, , Poland

Site Status

Gabinet Endoskopii Przewodu Pokarmowego

Krakow, , Poland

Site Status

Krakowskie Centrum Medyczne Sp. z o.o

Krakow, , Poland

Site Status

Centrum Opieki Zdrowotnej Orkan-Med Stec-Michalska Sp.J.

Ksawerów, , Poland

Site Status

Santa Familia, Centrum Badan, Profilaktyki i Leczenia

Lodz, , Poland

Site Status

Centrum Innowacyjnych Terapii Sp. z o.o.

Piaseczno, , Poland

Site Status

Clinical Research Center Spolka z organiczna odpowiedzialnoscia Medic-R Sp. k.

Poznan, , Poland

Site Status

Gabinet Lekarski Dr. Hab. N. Med. Bartosz Korczowski

Rzeszów, , Poland

Site Status

Endoskopia Sp. z o.o.

Sopot, , Poland

Site Status

Twoja Przychodnia-Szczecinskie Centrum Medyczne

Szczecin, , Poland

Site Status

GASTROMED Kopon, Zmudzkinski i Wspolnicy Sp. j. Specjalistyczne Centrum Gastrologii i Endoskopii

Torun, , Poland

Site Status

H-T.Centrum Medyczne Spolka z Ograniczona Odpowiedzialnoscia Sp.K.

Tychy, , Poland

Site Status

Centrum Zdrowia MDM

Warsaw, , Poland

Site Status

Bodyclinic

Warsaw, , Poland

Site Status

Centralny Szpital Kliniczny Ministerstwa Spraw Wewnetrznych i Administacji w Warszawie

Warsaw, , Poland

Site Status

Niepubliczny Zaklad Opieki Zrodotnej VIVAMED Jadwige Miecz

Warsaw, , Poland

Site Status

Centrum Medyczne Oporow

Wroclaw, , Poland

Site Status

Hospital da Senhora da Oliveira Guimaraes, E.P.E.

Guimarães, , Portugal

Site Status

Centro Hospitalar de Sao Joao, EPE

Porto, , Portugal

Site Status

SC MedLife SA, Gastroenterologie

Bucharest, , Romania

Site Status

Spitalul Clinic Colentina - Sectia de Spitulal Clinic Colentina, Gastroenterologie

Bucharest, , Romania

Site Status

Cabinet Medical Individual Dr Tirnaveanue Amelita, Gastroenterologie

Oradea, , Romania

Site Status

Cabinet Particular Policlinic Algomed SRL

Timișoara, , Romania

Site Status

State Budgetary Healthcare Institution "Chelyabinski Regional Clinical Hospital"

Chelyabinsk, , Russia

Site Status

State Budgetary Institution of Health Irkustsk Order "Badge of Honor" Regional Clinical Hospital

Irkutsk, , Russia

Site Status

Federal State Budgetary Institution of Science Federal Research Center of Nutrition, Biotechnology and Food Safety

Moscow, , Russia

Site Status

State Budgetary Healthcare Institution of Moscow "City Clinical Hospital # 24 of Healthcare Department of Moscow"

Moscow, , Russia

Site Status

State Budgetary Healthcare Institution of Moscow Region "Moscow Regional Clinical Research Institute n.a. M.F. Vladimirskiy"

Moscow, , Russia

Site Status

State Budgetary Healthcare Institution of Nizhny Novgorod Region "Nizhny Novgorod Regional Clinical Hospital n.a. N.A.

Nizhny Novgorod, , Russia

Site Status

State Budgetary Institution of Health of Novosibirsk Region "City Clinical Hospital #12"

Novosibirsk, , Russia

Site Status

State Budgetary Healthcare Institution of the Novosibirsk Region "State Novosibirsk Regional Clinical Hospital"

Novosibirsk, , Russia

Site Status

Saint Petersburg State Budgetary Healthcare Institution "City Polyclinic #38"

Saint Petersburg, , Russia

Site Status

"Riat" LLC

Saint Petersburg, , Russia

Site Status

"Scientific Research Centre ECO-safety" LLC

Saint Petersburg, , Russia

Site Status

"PolyClinic EXPERT" LLC

Saint Petersburg, , Russia

Site Status

State Healthcare Institution "Regional Clinical Hospital"

Saratov, , Russia

Site Status

Treatment and Prevention Interdistrict Institution "Smolenskie kliniki" LLC

Smolensk, , Russia

Site Status

State Autonomous Health Institution of the Tyumen Region "Multidisciplinary Consultative and Diagnostic Center"

Tyumen, , Russia

Site Status

Zvezdara University Medical Center

Belgrade, , Serbia

Site Status

Singapore General Hospital

Singapore, , Singapore

Site Status

KM Management, s.r.o., Gastroenterologicke a hepatologicke centrum Nitra

Nitra, , Slovakia

Site Status

Dr MJ Prins

Cape Town, , South Africa

Site Status

Peermed Clinical Trial Centre

Johannesburg, , South Africa

Site Status

The Catholic University of Korea, St. Vincent's Hospital

Suwon, Gyeonggi-do, South Korea

Site Status

Pusan National University Hospital

Busan, , South Korea

Site Status

Yeungnam University Hospital

Daegu, , South Korea

Site Status

Kangbuk Samsung Hospital

Seoul, , South Korea

Site Status

Yonsei University Health System, Severance Hospital

Seoul, , South Korea

Site Status

Asan Medical Center

Seoul, , South Korea

Site Status

Division of Gastroenterology, Department of Medicine, Samsung Medical Center

Seoul, , South Korea

Site Status

Hyung Hee University Hospital

Seoul, , South Korea

Site Status

Yonsei University Wonju Severance Christian Hospital

Wŏnju, , South Korea

Site Status

Centro Medico Teknon

Barcelona, , Spain

Site Status

Hospital Clinico San Carlos

Madrid, , Spain

Site Status

Hospital Universitario de Fuenlabrada

Madrid, , Spain

Site Status

Hospital Universitario Central de Asturias

Oviedo, , Spain

Site Status

Hospital Universitario Virgen del Rocio

Seville, , Spain

Site Status

Danderyds Sjukhus AB

Danderyd, , Sweden

Site Status

Skane University Hospital

Malmo, , Sweden

Site Status

Akademiska Sjukhuset

Uppsala, , Sweden

Site Status

Gastroenterologische Praxis Balsiger, Seibold und Partner

Bern, , Switzerland

Site Status

Universitatsspital Zurich

Zurich, , Switzerland

Site Status

Changhua Christian Hospital

Chang-hua, , Taiwan

Site Status

National Taiwan University Hospital

Taipei, , Taiwan

Site Status

Mackay Memorial Hospital, Taipei

Taipei, , Taiwan

Site Status

Chang Gung Medical Foundation, Chang Gung Memorial Hospital, Linkou Branch

Taoyuan District, , Taiwan

Site Status

Municipal Institution "Cherkasy Regional Hospital of Cherkasy Regional Council", Gastroenterology Department

Cherkasy, , Ukraine

Site Status

Municipal City Clinical Hospital of the Emergency Medical Care, 1 st Therapy Department. Danylo Halytsky Lviv National Medical

Chernivtsi, , Ukraine

Site Status

Regional Municipal Institution "Chernivtsi Regional Clinical Hospital", Surgical Department

Chernivtsi, , Ukraine

Site Status

State Institution "Institute of Gastroenterology of National Academy of Medical Sciences of Ukraine"

Dnipropetrovsk, , Ukraine

Site Status

Ivanto-Frankivsk Central City Clinic Hospital, Therapy Department #1. State Higher Education Institution Ivano-Frankivsk National

Ivano-Frankivsk, , Ukraine

Site Status

Municipal Health Care Institution "Kharkiv City Clinical Hospital #2 named after prof. O. O. Shalimov", Proctology Department

Kharkiv, , Ukraine

Site Status

L.T. Mala State Institution "National Institute of Therapy of National Academy of Medical Sciences of Ukraine"

Kharkiv, , Ukraine

Site Status

Municipal Institution of Health Care "Regional Hospital of War Veterans", Therapeutic Department No1

Kharkiv, , Ukraine

Site Status

Treatment and Diagnostic Center of Private Enterprise of Private Production Company "Acinus"

Kropyvnytskyi, , Ukraine

Site Status

Kyiv City Clinical Hospital No. 18, Proctology Department

Kyiv, , Ukraine

Site Status

Municipal Non-profit Enterprise "Consultative and Diagnostic Center" of Pechersk District of Kyiv, Therapy Department

Kyiv, , Ukraine

Site Status

Odesa Clinical Railway Hospital Branch of "Healthcare Center" of Public joint stock company "Ukrainian Railway"

Odesa, , Ukraine

Site Status

Municipal Institution "Odesa Regional Clinical Hospital", Regional Gastroenterology Center based on Surgery Department

Odesa, , Ukraine

Site Status

Ternopil University Hospital, Regional Center of Gastroenterology with Hepatology

Ternopil, , Ukraine

Site Status

Vinnytsia Regional Clinical Hospital of War Veterans, Therapy Department #1

Vinnytsia, , Ukraine

Site Status

M.I. Pyrogov Vinnytsia Regional Clinical Hospital, Gastroenterology Department

Vinnytsia, , Ukraine

Site Status

Medical Center LLC "Health Clinic"

Vinnytsia, , Ukraine

Site Status

Municipal Institution "Zaporizhzhya Regional Clinical Hospital" of Zaporizhzhya Regional Council

Zaporizhzhya, , Ukraine

Site Status

The Pennine Acute Hospitals NHS Trust

Bury, , United Kingdom

Site Status

Cambridge University Hospital NHS Foundation Trust

Cambridge, , United Kingdom

Site Status

Royal Derby Hospital

Derby, , United Kingdom

Site Status

NHS Lothian

Edinburgh, , United Kingdom

Site Status

Glasgow Clinical Research Facility - Queen Elizabeth University Hospital

Glasgow, , United Kingdom

Site Status

NHS Greater Glasgow and Clyde

Glasgow, , United Kingdom

Site Status

Wycombe Hospital

High Wycombe, , United Kingdom

Site Status

Imperial College Healthcare NHS Trust, St Mary's Hospital

London, , United Kingdom

Site Status

Norfolk and Norwich University Hospital NHS Foundation Trust

Norwich, , United Kingdom

Site Status

Biomedical Research Unit

Nottingham, , United Kingdom

Site Status

Oxford University Hospitals NHS Foundation Trust

Oxford, , United Kingdom

Site Status

St Helens and Knowsley Teaching Hospitals NHS Trust

Prescot, , United Kingdom

Site Status

Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility

Southampton, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Australia Austria Belgium Bulgaria Canada Croatia Czechia France Georgia Germany Greece Hong Kong Hungary India Ireland Israel Italy Japan Malaysia Mexico Netherlands New Zealand Norway Poland Portugal Romania Russia Serbia Singapore Slovakia South Africa South Korea Spain Sweden Switzerland Taiwan Ukraine United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Nakase H, Danese S, Reinisch W, Ritter T, Liang Y, Wendt E, Levesque BG, Yoon OK, Tian Y, Zhuo L, Karouzakis E, Bauer Y, Oortwijn A, Kaise T, Malkov VA, Hibi T. Mediators of Filgotinib Treatment Effects in Ulcerative Colitis: Exploring Circulating Biomarkers in the Phase 2b/3 SELECTION Study. Inflamm Bowel Dis. 2025 Apr 10;31(4):1095-1108. doi: 10.1093/ibd/izae278.

Reference Type DERIVED
PMID: 39656830 (View on PubMed)

Schreiber S, Feagan BG, Louis E, Hisamatsu T, Hibi T, Dron L, Jamoul C, Patel H, Harris K, Taliadouros V, Oortwijn A, Peyrin-Biroulet L. Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study. United European Gastroenterol J. 2024 Nov;12(9):1243-1255. doi: 10.1002/ueg2.12686. Epub 2024 Oct 25.

Reference Type DERIVED
PMID: 39452892 (View on PubMed)

Watanabe K, Peyrin-Biroulet L, Danese S, Fujitani Y, Faes M, Oortwijn A, Lindsay JO, Rogler G, Hibi T. Impact of Concomitant Thiopurine on the Efficacy and Safety of Filgotinib in Patients with Ulcerative Colitis: Post Hoc Analysis of the Phase 2b/3 SELECTION Study. J Crohns Colitis. 2024 Jun 3;18(6):801-811. doi: 10.1093/ecco-jcc/jjad201.

Reference Type DERIVED
PMID: 38019901 (View on PubMed)

Schreiber S, Rogler G, Watanabe M, Vermeire S, Maaser C, Danese S, Faes M, Van Hoek P, Hsieh J, Moerch U, Zhou Y, de Haas A, Rudolph C, Oortwijn A, Loftus EV Jr. Integrated safety analysis of filgotinib for ulcerative colitis: Results from SELECTION and SELECTIONLTE. Aliment Pharmacol Ther. 2023 Nov;58(9):874-887. doi: 10.1111/apt.17674. Epub 2023 Sep 18.

Reference Type DERIVED
PMID: 37718932 (View on PubMed)

Vermeire S, Feagan BG, Peyrin-Biroulet L, Oortwijn A, Faes M, de Haas A, Rogler G. Withdrawal and Re-treatment with Filgotinib in Ulcerative Colitis: Post Hoc Analyses of the Phase 2b/3 SELECTION and SELECTIONLTE Studies. J Crohns Colitis. 2024 Jan 27;18(1):54-64. doi: 10.1093/ecco-jcc/jjad123.

Reference Type DERIVED
PMID: 37540206 (View on PubMed)

Lu X, Zhou ZY, Xin Y, Wang MJ, Gray E, Jairath V, Lindsay JO. Matching-Adjusted Indirect Comparisons of Filgotinib vs Vedolizumab, Tofacitinib, and Ustekinumab for Moderately to Severely Active Ulcerative Colitis. Inflamm Bowel Dis. 2024 Jan 5;30(1):64-77. doi: 10.1093/ibd/izad037.

Reference Type DERIVED
PMID: 36946138 (View on PubMed)

Dotan I, Feagan BG, Taliadouros V, Oortwijn A, Rudolph C, de Haas A, Santermans E, Hsieh J, Peyrin-Biroulet L, Hibi T. Efficacy of Filgotinib in Patients with Ulcerative Colitis by Line of Therapy in the Phase 2b/3 SELECTION Trial. J Crohns Colitis. 2023 Aug 21;17(8):1207-1216. doi: 10.1093/ecco-jcc/jjad039.

Reference Type DERIVED
PMID: 36928705 (View on PubMed)

Schreiber S, Feagan BG, Peyrin-Biroulet L, Vermeire S, Faes M, Harris K, Oortwijn A, Daniele P, Patel H, Danese S. Filgotinib Improved Health-Related Quality of Life and Led to Comprehensive Disease Control in Individuals with Ulcerative Colitis: Data from the SELECTION Trial. J Crohns Colitis. 2023 Jun 16;17(6):863-875. doi: 10.1093/ecco-jcc/jjad018.

Reference Type DERIVED
PMID: 36756874 (View on PubMed)

Loftus EV, Vermeire S, Feagan BG, Le Brun FO, Oortwijn A, Moerch U, Sandborn WJ, Hibi T. Corticosteroid-Sparing Effects of Filgotinib in Moderately to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study. J Crohns Colitis. 2023 Mar 18;17(2):211-220. doi: 10.1093/ecco-jcc/jjac122.

Reference Type DERIVED
PMID: 36006011 (View on PubMed)

Feagan BG, Danese S, Loftus EV Jr, Vermeire S, Schreiber S, Ritter T, Fogel R, Mehta R, Nijhawan S, Kempinski R, Filip R, Hospodarskyy I, Seidler U, Seibold F, Beales ILP, Kim HJ, McNally J, Yun C, Zhao S, Liu X, Hsueh CH, Tasset C, Besuyen R, Watanabe M, Sandborn WJ, Rogler G, Hibi T, Peyrin-Biroulet L. Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial. Lancet. 2021 Jun 19;397(10292):2372-2384. doi: 10.1016/S0140-6736(21)00666-8. Epub 2021 Jun 3.

Reference Type DERIVED
PMID: 34090625 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2016-001392-78

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

GS-US-418-3898

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.